<生产厂家价格>

4-甲氨基吡啶

4-甲氨基吡啶用途

吡啶-4-基甲胺是一种生物化学试剂,可作为生物材料或有机化合物进行生命科学相关研究。

4-甲氨基吡啶名称

[ CAS 号 ]:
3731-53-1

[ 中文名 ]:
4-甲氨基吡啶

[ 英文名 ]:
4-picolinylamine

[中文别名 ]:

[英文别名 ]:

a-Amino-g-picoline
4-picolinylamine
α-Amino-γ-picoline
1-(4-Pyridinyl)methanamine
4-Picolylamine
4-(Aminomethyl)pyridine
4-Aminomethylpyridine
Pyridin-4-ylmethanamine
4-pyridylmethylamine
4-Pyridinemethanamine

4-甲氨基吡啶生物活性

[ 描述 ]:

吡啶-4-基甲胺是一种生物化学试剂,可作为生物材料或有机化合物进行生命科学相关研究。

[ 相关类别 ]:

研究领域 >> 其他

4-甲氨基吡啶物理化学性质

[ 密度 ]:
1.1±0.1 g/cm3

[ 沸点 ]:
230.0±0.0 °C at 760 mmHg

[ 熔点 ]:
−8 °C(lit.)

[ 分子式 ]:
C₆H₈N₂

[ 分子量 ]:
108.14

[ 闪点 ]:
108.3±0.0 °C

[ 精确质量 ]:
108.068748

[ PSA ]:
38.91000

[ LogP ]:
-0.40

[ 外观性状 ]:
黄色

[ 蒸汽压 ]:
0.1±0.4 mmHg at 25°C

[ 折射率 ]:
1.552

[ 储存条件 ]:
室温

4-甲氨基吡啶MSDS

详细MSDS(安全技术说明书)

4-甲氨基吡啶安全信息

[ 符号 ]:

GHS05

[ 信号词 ]:
Danger

[ 危害声明 ]:
H314

[ 警示性声明 ]:
P280-P305 + P351 + P338-P310

[ 个人防护装备 ]:
Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ 危害码 (欧洲) ]:
C:Corrosive;

[ 风险声明 (欧洲) ]:
R34

[ 安全声明 (欧洲) ]:
S26-S36/37/39-S45

[ 危险品运输编码 ]:
UN 2735 8/PG 2

[ WGK德国 ]:
3

[ 包装等级 ]:
III

[ 危险类别 ]:
8

[ 海关编码 ]:
2933399090

4-甲氨基吡啶上下游产品

4-甲氨基吡啶上游产品

4-甲氨基吡啶下游产品

4-甲氨基吡啶海关

[ 海关编码 ]: 2933399090

[ 中文概述 ]:
2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-甲氨基吡啶文献

A sensitive and selective chemosensor for GSSG detection based on the recovered fluorescence of NDPA-Fe₃O₄@SiO₂-Cu(II) nanomaterial.

Biosens. Bioelectron. 48 , 138-44, (2013)

A sensitive and selective sensor for oxidized glutathione (GSSG) detection based on the recovered fluorescence of naphthalimide-DPA (NDPA)-Fe₃O₄@SiO₂-Cu(II) system is reported. NDPA-Fe3Fe₃O₄@SiO₂ was ...

Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors.

Eur. J. Med. Chem. 94 , 175-94, (2015)

An approach for optimization of epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors using truncated thienopyrimidine structures combined with enzymatic assay has been evaluated. This...

[Synthesis of 3-nitro-1-nitroso-1-(4-pyridylmethyl)guanidine and related compounds].

Eisei Shikenjo Hokoku. (102) , 105-8, (1984)

更多文献